<DOC>
	<DOCNO>NCT02547805</DOCNO>
	<brief_summary>Evaluate safety , tolerability , efficacy 28 day treatment ALLN-177 reduce urinary oxalate excretion patient secondary hyperoxaluria kidney stone .</brief_summary>
	<brief_title>Evaluate Effect ALLN-177 Reducing Urinary Oxalate Patients With Secondary Hyperoxaluria Kidney Stones Over 28 Days</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , placebo control study evaluate efficacy ALLN 177 compare placebo reduce urinary excretion oxalate subject secondary hyperoxaluria kidney stone . ALLN-177 orally administer form oxalate decarboxylase . The goal therapy ALLN-177 reduce urinary oxalate excretion decrease absorption oxalate gastrointestinal tract . Eligible subject randomize 28 day treatment ALLN-177 ( 7,500 unit ) placebo three time daily meal . Urinary oxalate excretion assess 24-hr urine collection throughout study . The study allow approximately 66 subject . The number enrol subject may increase maximum 100 follow interim analysis .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Hyperoxaluria</mesh_term>
	<criteria>History enteric idiopathic hyperoxaluria kidney stone Urinary oxalate â‰¥ 50 mg/24 hour Hyperuricosuria Glomerular filtration rate &lt; 45 mL/min/1.73m2 Hypercalcemia hyperthyroidism Autoimmune disorder require systemic steroid Acute renal colic , primary hyperoxaluria , pure uric acid and/or cysteine stone , renal tubular acidosis , chronic urinary tract infection , acute renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Urine Oxalate</keyword>
	<keyword>Nephrolithiasis</keyword>
	<keyword>Kidney Stones</keyword>
	<keyword>Hyperoxaluria</keyword>
	<keyword>Enteric Hyperoxaluria</keyword>
	<keyword>Idiopathic Hyperoxaluria</keyword>
	<keyword>Urological Diseases</keyword>
	<keyword>Kidney Diseases</keyword>
	<keyword>Supersaturation</keyword>
	<keyword>Dietary Oxalate</keyword>
</DOC>